3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neuroendocrine Tumors
4
Differentiated Thyroid Cancer
2
Adenoma, Islet Cell
2
Tuberous Sclerosis
1
Thyroid Cancer, Papillary
1
Pituitary Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Insulinoma
1
Hyperinsulinism
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gastroenteropancreatic Neuroendocrine Tumors
1
Congenital Hyperinsulinism
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoid Tumor
1
Advanced Extrapulmonary Neuroendocrine Cancer
1
Adenocarcinoma, Follicular
1
Acromegaly
1
Interventions
pasireotide
5
lanreotide
3
Octreotide
3
Cabergoline
2
pegvisomant
1
Transcranial Magnetic Stimulation
1
Tissue Banks
1
Surgical Procedures, Operative
1
Solutions
1
Radiosurgery
1
Observation
1
Magnetic Resonance Spectroscopy
1
Injections
1
Dosage Forms
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acromegaly
×
Injections
×
Endocrine
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled